Clinical Trial Update: 68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for the PET/CT imaging agent 68Ga-NOTA-RM26 in patients with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-NOTA-RM26 (NOTA-RM26)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Prostate Cancer | Phase 1 | Status: UNKNOWN